Instituto de Investigaciones Biomédicas de A Coruña (INIBIC)

2020

1. A Pathogenic Galactosidase A Mutation Coexisting With an MYBPC3 Mutation in a Female Patient With Hypertrophic Cardiomyopathy

   Canadian Journal of Cardiology, Vol. 36, Núm. 9, pp. 1554.e1-1554.e3

2. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry

   Journal of the American Heart Association, Vol. 9, Núm. 1

3. Categorización de los programas de prevención y rehabilitación cardiaca en España

   Enfermería en cardiología: revista científica e informativa de la Asociación Española de Enfermería en Cardiología, Núm. 81, pp. 12-20

4. Circulating miR-181a-5p as a new biomarker for acute cellular rejection in heart transplantation

   Journal of Heart and Lung Transplantation, Vol. 39, Núm. 10, pp. 1100-1108

5. Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit

   Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 652-659

6. Cryptic Splice-Altering Variants in MYBPC3 Are a Prevalent Cause of Hypertrophic Cardiomyopathy

   Circulation: Genomic and Precision Medicine, Vol. 13, Núm. 3, pp. E002905

7. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study

   Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 25, Núm. 4, pp. 316-323

8. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study

   Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 14-20

9. European society of cardiology: Cardiovascular disease statistics 2019

   European Heart Journal, Vol. 41, Núm. 1, pp. 12-85

10. Gender differences in health-related quality of life in patients with systolic heart failure: Results of the vida multicenter study

    Journal of Clinical Medicine, Vol. 9, Núm. 9, pp. 1-15

11. Hemodinámica. Estudio MAREC, diagnóstico de la situación de Enfermería en España

    Enfermería en cardiología: revista científica e informativa de la Asociación Española de Enfermería en Cardiología, Núm. 81, pp. 21-31

12. Hyperkalemia in heart failure patients in Spain and its impact on guidelines and recommendations: ESC-EORP-HFA Heart Failure Long-Term Registry

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 313-323

13. INR during stroke and bleeding in patients with atrial fibrillation and on vitamin K antagonists

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 131-138

14. Impact on mortality after implementation of a network for ST-segment elevation myocardial infarction care. The IPHENAMIC study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 632-642

15. Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study

    European Journal of Internal Medicine, Vol. 78, pp. 63-68

16. La INR durante los ictus y las hemorragias en pacientes con fibrilación auricular tratados con antagonistas de la vitamina K

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 131-138

17. Presence of bacterial DNA in thrombotic material of patients with myocardial infarction

    Scientific Reports, Vol. 10, Núm. 1

18. Prognostic impact of inappropriate doses of direct oral anticoagulants in clinical practice

    Revista Espanola de Cardiologia, Vol. 73, Núm. 4, pp. 329-330

19. Proyecto MAREC: situación de la enfermería en insuficiencia cardiaca en España

    Enfermería en cardiología: revista científica e informativa de la Asociación Española de Enfermería en Cardiología, Núm. 80, pp. 11-23

20. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

    Annals of Medicine, Vol. 52, Núm. 6, pp. 300-309